Sharon Hassin-Baer

Summary

Affiliation: Tel Aviv University
Country: Israel

Publications

  1. ncbi request reprint Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease
    Oren S Cohen
    Parkinson s Disease and Movement disorders Clinic, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Cogn Behav Neurol 20:68-72. 2007
  2. ncbi request reprint Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia
    S Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    J Neurol 246:716-9. 1999
  3. doi request reprint Gender effect on time to levodopa-induced dyskinesias
    Sharon Hassin-Baer
    Department of Neurology, Parkinson and Movement Disorders Clinic, Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel
    J Neurol 258:2048-53. 2011
  4. doi request reprint Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?
    Sharon Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, 52621, Tel Hashomer, Israel
    J Neural Transm 118:539-43. 2011
  5. doi request reprint The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel
    Sharon Hassin-Baer
    The Parkinson s Disease and Movement Disorders Clinic, Dept of Neurology and Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel Hashomer, 52621, Israel
    J Neurol 256:483-7. 2009
  6. ncbi request reprint Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications
    Sharon Hassin-Baer
    Department of Neurology and Parkinson s Disease and Movement Disorders Clinic, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Clin Neuropharmacol 29:305-11. 2006
  7. ncbi request reprint Botulinum toxin injections for children with excessive drooling
    Sharon Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    J Child Neurol 20:120-3. 2005
  8. ncbi request reprint Stiff-person syndrome following West Nile fever
    Sharon Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Arch Neurol 61:938-41. 2004
  9. ncbi request reprint The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease
    Lior Greenbaum
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel Parkinson s Disease and Movement Disorders Clinic, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    Parkinsonism Relat Disord 19:1053-6. 2013
  10. doi request reprint The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease
    Oren S Cohen
    Sagol Neuroscience Center and Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    J Geriatr Psychiatry Neurol 25:71-7. 2012

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease
    Oren S Cohen
    Parkinson s Disease and Movement disorders Clinic, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Cogn Behav Neurol 20:68-72. 2007
    ..To test a possible association between the educational level (EL), cognitive performance, and neuropsychiatric features in Parkinson disease (PD)...
  2. ncbi request reprint Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia
    S Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    J Neurol 246:716-9. 1999
    ..In this heterogeneous group of patients with cerebellar ataxia we found no mutations in the ATM gene. We conclude that mutations in the ATM gene are probably not a common cause for cerebellar ataxia other than AT...
  3. doi request reprint Gender effect on time to levodopa-induced dyskinesias
    Sharon Hassin-Baer
    Department of Neurology, Parkinson and Movement Disorders Clinic, Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel
    J Neurol 258:2048-53. 2011
    ..Younger age at PD diagnosis and a longer time until starting levodopa are associated with both higher likelihood to develop LID, and a shorter latency until LID were observed...
  4. doi request reprint Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?
    Sharon Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, 52621, Tel Hashomer, Israel
    J Neural Transm 118:539-43. 2011
    ..5 vs. 25%, p = 0.01). CRP levels in patients with PD are associated with a higher prevalence of CAD, but are not associated with PD duration or severity, or with neuropsychiatric complications other than reported depression...
  5. doi request reprint The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel
    Sharon Hassin-Baer
    The Parkinson s Disease and Movement Disorders Clinic, Dept of Neurology and Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel Hashomer, 52621, Israel
    J Neurol 256:483-7. 2009
    ..An association between malignant melanoma (MM) and PD was also recently reported. The nature of this association is still elusive...
  6. ncbi request reprint Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications
    Sharon Hassin-Baer
    Department of Neurology and Parkinson s Disease and Movement Disorders Clinic, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Clin Neuropharmacol 29:305-11. 2006
    ..To determine whether plasma homocysteine (Hcy) levels are associated with clinical characteristics, neuropsychological and psychiatric manifestations and cardiovascular comorbidity in patients with Parkinson disease (PD)...
  7. ncbi request reprint Botulinum toxin injections for children with excessive drooling
    Sharon Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    J Child Neurol 20:120-3. 2005
    ..These results underscore the need for further studies to establish the efficacy of this treatment in children...
  8. ncbi request reprint Stiff-person syndrome following West Nile fever
    Sharon Hassin-Baer
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Arch Neurol 61:938-41. 2004
    ..Stiff-person syndrome is a rare autoimmune disorder associated with antibodies against glutamic acid decarboxylase (GAD), the key enzyme in gamma-aminobutyric acid synthesis. In most cases, a trigger cannot be identified...
  9. ncbi request reprint The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease
    Lior Greenbaum
    Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel Parkinson s Disease and Movement Disorders Clinic, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    Parkinsonism Relat Disord 19:1053-6. 2013
    ..The effect of STN-DBS surgery in patients carrying this mutation has not been systematically studied. We therefore performed a case-control study to evaluate the impact of the G2019S mutation status on the outcomes of bilateral STN-DBS...
  10. doi request reprint The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease
    Oren S Cohen
    Sagol Neuroscience Center and Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    J Geriatr Psychiatry Neurol 25:71-7. 2012
    ..The Frontal Assessment Battery (FAB) was developed to assess frontal lobe functions. However, many studies found that it also correlated with a variety of other general neuropsychological tests...
  11. doi request reprint Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson's disease
    Omer Porat
    Department of Neurology and The Movement Disorders Unit, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    J Neuropsychiatry Clin Neurosci 21:398-405. 2009
    ..Compared with patients who improved, patients who had deteriorated behaviorally had similar prevalence and severity of preoperative behavioral symptoms but significantly shorter disease duration...
  12. doi request reprint Phenotype of the 202 adenine deletion in the parkin gene: 40 years of follow-up
    Sharon Hassin-Baer
    The Sagol Neuroscience Center, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel
    Mov Disord 26:719-22. 2011
    ..We describe the four decades follow-up of 14 parkin patients belonging to two large eight-generation-long in-bred Muslim-Arab kindreds...
  13. ncbi request reprint Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease
    Natalie Kaplan
    The Parkinson Disease and Movement Disorders Clinic, Department of Neurology and Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel
    J Mol Neurosci 53:183-8. 2014
    ..96 (95 % CI, 2.3-10.9; p = 4.1 × 10(-5)). This finding should be validated in larger, ethnically diverse PD populations, and the biological mechanism should be explored. ..
  14. pmc Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease
    Simon D Israeli-Korn
    Parkinson s Disease and Movement disorders Clinic, Sagol Neuroscience Center and Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel
    PLoS ONE 8:e65270. 2013
    ..To evaluate how bilateral subthalamic nucleus deep brain stimulation (STN-DBS) affects visuo-motor coordination (VMC) in patients with Parkinson's disease (PD)...
  15. doi request reprint Parkinson's disease genes do not segregate with breast cancer genes' loci
    Efrat Kravitz
    The Parkinson Disease and Movement Disorders Clinic, and Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    Cancer Epidemiol Biomarkers Prev 22:1464-72. 2013
    ....
  16. ncbi request reprint Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations
    Lilach Ephraty
    Department of Neurology, The Sagol Neuroscience Center, Tel Aviv University, Tel Aviv, Israel
    Mov Disord 22:566-9. 2007
    ..Their father had a psychiatric disorder but no Parkinsonism. This report expands the phenotypic profile of PINK1-related disease, presenting unique psychiatric and cognitive features as part of the clinical picture...
  17. ncbi request reprint Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study
    Ruth Djaldetti
    Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49100, Israel
    Clin Neuropharmacol 26:322-6. 2003
    ..Clinical trials with etilevodopa/carbidopa tablets should be carried out in PD patients with response fluctuations such as "delayed on" and "dose failures"...
  18. ncbi request reprint Exploring hypersexual behavior in men with Parkinson's disease: is it compulsive sexual behavior?
    Gila Bronner
    Department of Urology, Sexual Medicine Center, Sheba Medical Center, Tel Hashomer, Israel
    J Parkinsons Dis 2:225-34. 2012
    ..Excessive sexual demands of parkinsonian men can lead to considerable tension within the couple. Thorough sexual interviews reveal that these cases may reflect various types of sexual dysfunctions that present as hypersexuality...
  19. ncbi request reprint Enhanced creative thinking under dopaminergic therapy in Parkinson disease
    Achinoam Faust-Socher
    Parkinson s Disease and Movement disorders Clinic, Department of Neurology, Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv
    Ann Neurol 75:935-42. 2014
    ..We aimed to examine PD patients' ability to perform creativity tasks compared to healthy controls and to verify whether creativity is related to an impulse control disorder (ICD) as a complication of dopaminergic therapy...
  20. doi request reprint Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis
    Gilad Yahalom
    The Parkinson Disease and Movement Disorders Clinic, Department of Neurology and Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Clin Neuropharmacol 36:78-83. 2013
    ..To present the long-term neurological outcome of Jewish Israeli patients with cerebrotendinous xanthomatosis (CTX) after several years of chenodeoxycholic acid (CDCA) treatment...
  21. ncbi request reprint Extended phenotype in the transthyretin Tyr77 familial amyloid polyneuropathy
    Alexander Lossos
    Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Jerusalem, Israel
    Eur Neurol 53:55-9. 2005
    ..Brain MRI in the proband showed multifocal white matter lesions. These features extend the reported Tyr77 phenotype and support the modifying effect of additional factors on the disease expression...
  22. ncbi request reprint Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism
    Sharon Hassin-Baer
    Department of Neurology, Sackler Faculty of Medicine, Chaim Sheba Medical Center, Tel Aviv University, Tel Hashomer 52621, Tel Aviv, Israel
    Clin Rheumatol 26:743-7. 2007
    ..These patients may present a subtype of SS patients in which the presence of aCL antibodies is associated with central nervous system involvement predominantly in the basal ganglia...
  23. ncbi request reprint Deep brain stimulation of the internal globus pallidus for refractory tardive dystonia
    Oren S Cohen
    Parkinson s Disease and Movement disorders Clinic, The Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Parkinsonism Relat Disord 13:541-4. 2007
    ..The favorable and prolonged response in our two patients suggests that deep brain stimulation may be an effective treatment for medically refractory tardive dystonia...
  24. ncbi request reprint Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments
    Leo Verhagen Metman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 19:1079-1084. 2004
    ..Taken together, these findings challenge the need for multiple baseline assessments as currently stipulated in core assessment protocols for surgical intervention in PD...
  25. ncbi request reprint Subthalamic stimulation for Parkinson's disease
    Zvi Israel
    Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel
    Isr Med Assoc J 7:458-63. 2005
    ..This article briefly reviews the indications, technique and postoperative management of patients undergoing subthalamic nucleus stimulation...